Universita Degli Studi Di Brescia

At Universita Degli Studi Di Brescia, clinical research in neoplasms focuses on skin cancer and related precancerous conditions, especially actinic keratosis and cutaneous squamous cell carcinoma. These studies are designed to assess how well treatments can reduce cancer risk, improve disease control, and support better long-term outcomes for patients.

• Evaluating treatment effectiveness in actinic keratosis and preventing progression to invasive disease
• Studying adjuvant therapy strategies for high-risk cutaneous squamous cell carcinoma
• Assessing whether new approaches can improve disease-free survival after standard cancer care

This work reflects a strong interest in both early skin lesion management and more advanced cancer treatment, with the goal of improving outcomes in dermatologic oncology.

Research in respiratory tract diseases at the Divisione di Pediatria includes studies of acute respiratory distress syndrome, a serious condition that can affect breathing and recovery in critically ill patients. The trials aim to explore new ways to reduce complications and improve survival-related outcomes.

• Testing therapies intended to improve lung recovery in acute respiratory distress syndrome
• Measuring whether treatment can increase time free from mechanical ventilation
• Exploring options that may help prevent longer-term respiratory damage

These studies are centered on better supportive care and treatment effectiveness for patients facing severe respiratory illness.

The site also supports research into immune system processes and rare inherited conditions such as WHIM syndrome. This area of work focuses on strengthening immune function, reducing infections, and understanding whether targeted treatment can offer lasting benefit for people with complex immune disorders.

• Examining treatments that may raise circulating neutrophil levels in WHIM syndrome
• Assessing long-term safety and tolerability in a rare immune condition
• Supporting better control of infections and immune-related symptoms

These trials highlight a translational approach to rare disease care, combining symptom improvement with broader immune support.

Across its clinical trial portfolio, Universita Degli Studi Di Brescia is contributing to research that spans oncology, respiratory disease, skin disorders, and immunology. The studies are broadly aimed at testing new therapies, comparing treatment options, and improving how clinicians manage both common and rare diseases.

• Comparing active treatment with placebo or standard care to clarify benefit
• Investigating whether new interventions can improve patient outcomes and safety
• Supporting evidence-based care for both chronic and severe conditions

With 7 trials and a large investigator network, the site shows an active commitment to advancing clinical research in multiple therapeutic areas.